Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | FT500 |
Trade Name | |
Synonyms | FT-500|FT 500 |
Drug Descriptions |
FT500 is a preparation of pluripotent cell line-derived natural-killer cells, which potentially increases T-cell recruitment to tumors, and may enhance anti-tumor immune response in combination with checkpoint inhibitors (Cancer Res 2018;78 (13 Suppl):Abstract nr 3576). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C158438 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + FT500 | Atezolizumab FT500 | 0 | 1 |
FT500 | FT500 | 0 | 1 |
FT500 + Nivolumab | FT500 Nivolumab | 0 | 1 |
FT500 + Pembrolizumab | FT500 Pembrolizumab | 0 | 1 |